Research ArticleAutoimmunity

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo

See allHide authors and affiliations

Science Translational Medicine  18 Jul 2018:
Vol. 10, Issue 450, eaam7710
DOI: 10.1126/scitranslmed.aam7710

Article Information

vol. 10 no. 450

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication January 17, 2017
  • Resubmitted April 26, 2018
  • Accepted for publication June 14, 2018
  • .

Author Information

  1. Jillian M. Richmond1,
  2. James P. Strassner1,
  3. Lucio Zapata Jr.1,
  4. Madhuri Garg1,
  5. Rebecca L. Riding1,
  6. Maggi A. Refat1,
  7. Xueli Fan1,
  8. Vincent Azzolino1,
  9. Andrea Tovar-Garza2,
  10. Naoya Tsurushita3,
  11. Amit G. Pandya2,
  12. J. Yun Tso3 and
  13. John E. Harris1,*
  1. 1Department of Dermatology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  2. 2University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  3. 3JN Biosciences LLC, Mountain View, CA 94043, USA.
  1. *Corresponding author. Email: john.harris{at}umassmed.edu

Altmetric

Article usage

Article usage: July 2018 to August 2019

AbstractFullPdf
Jul 20186332267424
Aug 20181445237179
Sep 2018971137134
Oct 2018747124118
Nov 20185928582
Dec 20185655723
Jan 20196287561
Feb 20195936242
Mar 20199328766
Apr 20196958553
May 20196507149
Jun 20197406242
Jul 201936841093
Aug 2019144873

Navigate This Article